obesity

Will Obesity Drugs Gain Soon?

Will Obesity Drugs Gain Soon?

Motley Fool

Deal Discussions Distract From Disappointing Obesity Drug Sales (video)

Deal Discussions Distract From Disappointing Obesity Drug Sales (video)

Motley Fool

Why Does Arena's Obesity Drug Have Abuse Potential?

Why Does Arena's Obesity Drug Have Abuse Potential?

Forbes

Obesity Drug Demand Still Low

Obesity Drug Demand Still Low

Motley Fool

Eisai/Arena obesity drug gets all-clear for June launch

Eisai/Arena obesity drug gets all-clear for June launch

Pharma Times, UK

DEA finally acts on Belviq, clearing Arena for diet drug's launch

DEA finally acts on Belviq, clearing Arena for diet drug's launch

Fierce Pharma

[video]Are Obesity Drugs a Lost Cause in Europe?

[video]Are Obesity Drugs a Lost Cause in Europe?

Motley Fool

Vivus And Anti-Obesity Sector Benefit From New Insurance Deal

Vivus And Anti-Obesity Sector Benefit From New Insurance Deal

Seeking Alpha

Exciting Catalysts Approaching for This Bet

Exciting Catalysts Approaching for This Bet

Motley Fool

Vivus Seeing Traction With Qsymia

Vivus Seeing Traction With Qsymia

Seeking Alpha